Selection of a Salvage Regimen for Relapsed or Refractory Classic Hodgkin Lymphoma in the Era of Novel Therapies

Hematology/Oncology Clinics of North America · Published 2026-01-02 · DOI 10.1016/j.hoc.2025.12.004

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.hoc.2025.12.004

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles